Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-24-000066

CHIEF OPERATING OFFICER sold 10,000 shares at an average $111.93 ($1,119,252)

  • CHIEF OPERATING OFFICER gave up 5,545 shares (to pay taxes)
  • CHIEF OPERATING OFFICER acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wassil Jim CHIEF OPERATING OFFICER 2024-09-03 Option exercise 10b5-1 +10,000 $2.42 $24,200 217,503 D: show line 1 in the form
Wassil Jim CHIEF OPERATING OFFICER 2024-09-03 Sale 10b5-1 −258 $108.01 $27,867 217,245 D: show line 2 in the form
Wassil Jim CHIEF OPERATING OFFICER 2024-09-03 Sale 10b5-1 −2,072 $110.08 $228,085 215,173 D: show line 3 in the form
Wassil Jim CHIEF OPERATING OFFICER 2024-09-03 Sale 10b5-1 −3,102 $111.02 $344,388 212,071 D: show line 4 in the form
Wassil Jim CHIEF OPERATING OFFICER 2024-09-03 Sale 10b5-1 −2,263 $111.85 $253,107 209,808 D: show line 5 in the form
Wassil Jim CHIEF OPERATING OFFICER 2024-09-03 Sale 10b5-1 −367 $112.95 $41,452 209,441 D: show line 6 in the form
Wassil Jim CHIEF OPERATING OFFICER 2024-09-03 Sale 10b5-1 −389 $114.25 $44,445 209,052 D: show line 7 in the form
Wassil Jim CHIEF OPERATING OFFICER 2024-09-03 Sale 10b5-1 −344 $115.15 $39,610 208,708 D: show line 8 in the form
Open-market sales · 10,000 sh · avg $111.93 · $1,119,252

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Wassil Jim CHIEF OPERATING OFFICER 2024-09-03 Option exercise · Stock Option (right to buy) 10b5-1 −10,000 52,638 D: show line 12 in the form
Loading xslF345X05/wk-form4_1725571164.xml…